Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: estradiol dehydrogenase inhibitors - Forendo Pharma

Drug Profile

Research programme: estradiol dehydrogenase inhibitors - Forendo Pharma

Alternative Names: 17-beta hydroxysteroid dehydrogenase inhibitors; 17-β HSD type-1 inhibitors; 17β-HSD1 inhibitors; Dual HSD inhibitors; Estradiol dehydrogenase inhibitors; HSD inhibitors programme; HSD programme; HSD-1; HSD17B1 inhibitor

Latest Information Update: 03 Jul 2013

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hormos Medical; Solvay Pharmaceuticals; University of Turku
  • Developer Abbott Laboratories; QuatRx Pharmaceuticals
  • Class
  • Mechanism of Action Estradiol dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Endometriosis
  • No development reported Breast cancer; Uterine leiomyoma

Most Recent Events

  • 19 Mar 2018 Forendo Pharma plans a phase I trial for FOR 6219 in Endometriosis in second quarter of 2018
  • 25 Jun 2013 Estradiol dehydrogenase inhibitors are still in Preclinical trials for Endometriosis in Finland
  • 25 Jun 2013 Forendo Pharma acquires estradiol dehydrogenase inhibitors programme from Hormos Medical
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top